American Journal of Psychiatry
- Volume 180
- Number 5
- May 2023
Editor’s Note
Editorials
Review and Overview
Publication date: 01 May 2023
Pages340–347Over the past decade, psychedelic compounds have emerged as potentially transformative therapeutics for a variety of intractable neuropsychiatric conditions. However, historically most of the basic science has utilized these compounds as probes to ...
https://doi.org/10.1176/appi.ajp.20230172Articles
Publication date: 22 February 2023
Pages348–356Objective: Trichotillomania and skin-picking disorder are underrecognized and often disabling conditions in which individuals repeatedly pull at their hair or pick at their skin, leading to noticeable hair loss or tissue damage. To date there is a severe ...
https://doi.org/10.1176/appi.ajp.20220737Publication date: 22 March 2023
Pages357–366Objective: Social anxiety disorder is common and impairing. The efficacy of pharmacotherapy is moderate, highlighting the need for alternative therapies. This study compared the efficacy of gaze-contingent music reward therapy (GC-MRT), an eye-tracking-...
https://doi.org/10.1176/appi.ajp.20220533Publication date: 09 March 2023
Pages367–376Objective: Negative symptoms are a primary cause of disability in schizophrenia for which there are no established pharmacotherapies. This study evaluated a novel psychosocial intervention that combined two evidence-based practices—motivational ...
https://doi.org/10.1176/appi.ajp.20220243Publication date: 22 March 2023
Pages377–385Objectives: The authors sought to study the safety of antipsychotic polypharmacy compared with monotherapy in specific dosage categories. Methods: Patients with schizophrenia (N=61,889; median follow-up, 14.8 years [IQR=7.4–22.0]) were identified from the ...
https://doi.org/10.1176/appi.ajp.20220446Publication date: 09 March 2023
Pages386–394Objective: Overdose risk during a course of treatment with medication for opioid use disorder (MOUD) has not been clearly delineated. The authors sought to address this gap by leveraging a new data set from three large pragmatic clinical trials of MOUD. ...
https://doi.org/10.1176/appi.ajp.20220312Letter to the Editor
Past Issues
View Issues Archive
Vol. 181 | No. 12
Vol. 181 | No. 11
Vol. 181 | No. 10
